Articles From: ARIAD Announces Follow-up Data from Phase 1 and PACE Trials of Ponatinib in Patients with T315I Mutation in Chronic Myeloid Leukemia to Two-in-Three Patients will Book Medical Appointments Online in Five Years, Accenture Forecasts


ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced safety and efficacy follow-up data on Iclusig ® (ponatinib), its approved BCR-ABL inhibitor, in patients with a baseline T315I mutation from its Phase 1 and Phase 2 PACE trials in heavily pretreated patients with resistant or intolerant chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). With a median follow-up of three years for CP-CML patients and nine months overall, Iclusig continues to exhibit responses in patients with the T315I mutation, for whom there is no other approved tyrosine kinase inhibitor (TKI) therapy.
Sign-up for ARIAD Announces Follow-up Data from Phase 1 and PACE Trials of Ponatinib in Patients with T315I Mutation in Chronic Myeloid Leukemia investment picks
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced long-term follow up data from the Phase 1 trial of Iclusig ® (ponatinib), its approved BCR-ABL inhibitor, in heavily pretreated patients with resistant or intolerant chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). The study now shows that with a median follow-up of four years in chronic phase CML (CP-CML) patients, Iclusig continues to demonstrate anti-leukemic activity in patients with limited treatment options and that responses have been maintained in CP-CML patients (n=43) with 72 percent having a major cytogenetic response (MCyR), 65 percent having a complete cytogenetic response (CCyR) and 56 percent having a major molecular response (MMR). Long-term safety data show that careful benefit-risk evaluations should guide decisions to use and maintain
Sign-up for ARIAD Announces Long-Term Safety and Efficacy Data of Ponatinib in Chronic-Phase Chronic Myeloid Leukemia from Phase 1 Clinical Trial investment picks
2014/12/9
Spirit Announces Transfer of Gulfstream Wing Programs to Triumph Group, Inc. Canada NewsWire WICHITA, Kan.
Sign-up for Spirit Announces Transfer of Gulfstream Wing Programs to Triumph Group, Inc. investment picks
2014/12/9
WICHITA, Kan.
Sign-up for Spirit Announces Transfer of Gulfstream Wing Programs to Triumph Group, Inc. investment picks
ROCKVILLE, Md., Dec.
Sign-up for Supernus Announces Paragraph IV ANDA Filing for Trokendi XR(R) investment picks
2014/12/9
LAFAYETTE, La.
Sign-up for PetroQuest Energy Announces Significant Discovery At Its Thunder Bayou Prospect investment picks
RUTHERFORD, N.J., Dec.
Sign-up for Cancer Genetics, Inc. to Receive $530,000 Through New Jersey Technology Business Tax Program investment picks
TD Ameritrade Holding Corporation (NYSE: AMTD) today announced company metrics for November 2014.
Sign-up for TD Ameritrade Reports Monthly Metrics investment picks
Sealed Air Corporation (“Sealed Air” or the “Company”) (NYSE:SEE) today announced that the final tender period for the previously announced offer to purchase its outstanding 8.125% Senior Notes due 2019 (the “2019 Notes”), expired at 11:59 p.m., New York City time, on December 8, 2014 (the “Expiration Time”). At the Expiration Time, $602,855,000 principal amount of 2019 Notes, or 80.4% of the aggregate principal amount outstanding, had been validly tendered and not withdrawn.
Sign-up for Sealed Air Announces Completion of Tender Offer for 8.125% Senior Notes Due 2019 investment picks
HARTSVILLE, S.C., Dec.
Sign-up for Sonoco's Waco Flexibles Facility Receives Gold Sustainability Star Award investment picks
2014/12/9
Primoris Services Corporation (NASDAQ Global Select: PRIM) (“Primoris” or “Company”) today announced a new industrial award valued at $11.5 million.
Sign-up for Primoris Services Corporation Announces Industrial Award Valued over $11 Million investment picks
Agilysys, Inc. (Nasdaq:AGYS), a leading provider of innovative information technology and hospitality software and services, today announced the promotion of Rehan Jaddi to senior vice president of customer support & service solutions, effective immediately.
Sign-up for Agilysys Promotes Jaddi to SVP of Customer Support & Service Solutions investment picks
Triumph Group, Inc. (NYSE:TGI) today announced the signing of a definitive agreement with Spirit AeroSystems Holdings, Inc. (NYSE: SPR) (“Spirit”) under which Triumph will take over production of the Gulfstream G650 and G280 wing programs located in Tulsa, Oklahoma.
Sign-up for Triumph Group Announces Agreement with Spirit AeroSystems to Assume Production of Gulfstream G650 and G280 Wing Programs investment picks
TriQuint Semiconductor, Inc. (NASDAQ: TQNT), a leading RF solutions supplier and technology innovator, announced that it earned continued Trusted Source Category 1A accreditation through 2016 from the Department of Defense (DoD). According to the certification, the accreditation of trust expresses the confidence of the DoD Defense Microelectronics Activity (DMEA) and the National Security Agency’s Trusted Access Program Office (TAPO) that TriQuint will continue to deliver trusted foundry microelectronic goods and services (category 1A) to end users which meet mission critical needs now and into the future.
Sign-up for TriQuint Continues Department of Defense’s Trusted Source Status investment picks
United Technologies (UTX) named on Tuesday Akhil Johri as its new chief financial officer, effective Jan.
Sign-up for United Technologies welcomes Akhil Johri back as CFO investment picks
2014/12/9
By William Boston FRANKFURT-- Volkswagen AG has poached a senior BMW executive in a reshuffle of its executive management aimed at bolstering the German car maker's VW brand which is struggling with weak profits and falling sales in major markets.
Sign-up for Volkswagen Poaches BMW Executive For Key Post--Update investment picks
CBRE Group, Inc. (NYSE:CBG) today announced that CBRE Services, Inc. ("CBRE Services") its wholly-owned subsidiary, intends to offer up to $125 million in aggregate principal amount of its 5.25% Senior Notes due 2025, subject to market and other conditions (the “Tack-On Notes”). The Tack-On Notes will be issued as additional notes under the same indenture as CBRE Services’ $300 million of 5.25% Senior Notes due 2025 that were issued on September 26, 2014.
Sign-up for CBRE Group, Inc. Announces Tack-on Offering of Senior Notes investment picks
2014/12/9
By Robert Wall LONDON-- Boeing Co.
Sign-up for Boeing Sees Strong Demand For New Aircraft--Update investment picks
2014/12/9
By Barbara Kollmeyer, MarketWatch Global stocks under pressure, yuan suffers record loss MADRID (MarketWatch) -- U.S. stock futures pointed to a rough start for Wall Street on Tuesday, amid fresh speculation the Federal Reserve may be close to pulling back its pledge to keep rates low, and sagging global markets, with China particularly hard hit.
Sign-up for UPDATE: U.S. stocks: Futures fall on oil worries, Fed rate-hike talk investment picks
Lower investable assets, cost of health care are delaying Retirement for Some Boomers CHICAGO , Dec.
Sign-up for 65 No Longer the Magic Age for Retirement investment picks
2014/12/9
By Christopher Alessi Siemens AG has no plans to walk away from a planned deal to acquire U.S. oil equipment manufacturer Dresser-Rand Group Inc., despite the slide in oil prices, Chief Executive Joe Kaeser said on Tuesday.
Sign-up for Siemens Won't Rethink Dresser-Rand Deal -- Update investment picks
By Ron Winslow SAN FRANCISCO--Four patients with a lethal blood disorder were able to forgo life-sustaining blood transfusions within 90 days after they were treated with a technique to replace the defective gene responsible for their disease, researchers said Monday.
Sign-up for Bluebird gene therapy shows promise for lethal blood disease investment picks
AutoZone's stock (AZO) was indicated higher in premarket trade Tuesday, after the auto parts retailer reported fiscal first-quarter profit and sales that beat expectations.
Sign-up for AutoZone's profit, sales rise above expectations investment picks
2014/12/9
LENOX Introduces Its First Curved Reciprocating Saw Blade in North America Canada NewsWire LENOX Gold Power Arc Curved Blades Offer Two Times Longer Blade Life EAST LONGMEADOW, Mass.
Sign-up for LENOX Introduces Its First Curved Reciprocating Saw Blade in North America investment picks
2014/12/9
LENOX Gold Power Arc Curved Blades Offer Two Times Longer Blade Life EAST LONGMEADOW, Mass.
Sign-up for LENOX Introduces Its First Curved Reciprocating Saw Blade in North America investment picks
2014/12/9
By Inti Landauro PARIS--European aerospace company Airbus Group NV (AIR.FR) said Tuesday it sold the 26.8% stake it owned in Finnish defense company Patria as part of a plan to divest assets considered not crucial.
Sign-up for Airbus Sells Stake in Finland's Patria investment picks
2014/12/9
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- Tesco PLC shares sank to their lowest level in 14 years Tuesday, leading losses on the FTSE 100, after the supermarket chain issued its fourth profit warning.
Sign-up for LONDON MARKETS: Tesco Tumbles In London To 14-year Low After Warning investment picks
2014/12/9
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- Tesco PLC shares sank to their lowest level in 14 years Tuesday, leading losses on the FTSE 100, after the supermarket chain issued its fourth profit warning.
Sign-up for UPDATE: Tesco tumbles in London to 14-year low after warning investment picks
Driven by demand for greater convenience, roughly two-in-three patients (64 percent) are expected to book medical appointments online by the end of 2019, generating $3.2 billion in added value or potential savings for U.S. health systems, according to new research by Accenture (NYSE:ACN). “Just as consumers use online tools to book restaurant reservations or request a cab, patients want the same experience in self-booking a doctor’s appointment,” said Dipak Patel, managing director of Accenture’s patient access solutions.
Sign-up for Two-in-Three Patients will Book Medical Appointments Online in Five Years, Accenture Forecasts investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: ARIAD Announces Follow-up Data from Phase 1 and PACE Trials of Ponatinib in Patients with T315I Mutation in Chronic Myeloid Leukemia to Two-in-Three Patients will Book Medical Appointments Online in Five Years, Accenture Forecasts
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent